drugset
drugset / Trial / NCT00215592

Open Label, Zonegran (Zonisamide) In Partial Onset Seizures

NCT00215592 ↗

Phase 4 Completed 1000 enrolled Eisai Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine the efficacy and safety of adjunctive open label Zonegran treatment in patients with refractory partial seizures.

Timeline

Start
2005-10
Primary completion
2007-07
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified — —

Indications

epilepsy